Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
| Image |  |
|---|---|
| Description | scientific article published on 05 October 2020 |
| Author/s |
author: M Subias Maria Jesus Rodrigo José M Fraile M J Cardiel Silvia Méndez-Martínez |
| Publication date | October 5, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |